Breckenridge Pharmaceutical recalled one lot of its 60 mg propranolol hydrochloride extended-release capsules nationwide Monday because the capsules may contain metal. The company told patients with capsules from that lot to stop taking them immediately and contact their prescriber or other health care provider for advice and a replacement.

The recall covers lot PK25110035, with a May 2029 expiration date. It was distributed to wholesalers and pharmacies across the United States from Oct. 26 through Nov. 4, 2026, in 100-capsule bottles with the National Drug Code 51991-817-01.

How to check your prescription

Empty medicine bottles on a pharmacy conveyor belt
Empty medicine bottles on a conveyor belt at a Nevada pharmacy in April 2015. File photograph.Airman 1st Class Rachel Loftis, U.S. Air Force / Public domain

The capsules are white, with “60” on the cap and “RD203” on the body, according to the product label on DailyMed. Those markings identify the strength and product. The lot number determines whether a bottle is part of this recall. If your pharmacy dispensed the capsules in its own bottle and the lot number is missing, ask the pharmacist to check the lot used to fill your prescription.

Breckenridge says to return unused capsules from the recalled lot to the pharmacy that dispensed them. If you experienced a problem that may be related to the capsules, the company advises contacting your health care provider. The company's recall service, Qualanex, answers questions at 855-736-0807 from 9 a.m. to 5 p.m. Eastern on weekdays.

Breckenridge says the recalled batch shared material with another batch in which metal was found. The other batch did not reach the market. The company says the fragments could cut tissue in the mouth or digestive tract, and it was unaware of any adverse events it had linked to the recall when it issued the notice.